Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Moleculin Biotech (MBRX)
Technical Analysis Report for NASDAQ stock MBRX Moleculin Biotech. Dated: 10 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MBRX Moleculin Biotech then click here. or read Experts views on Moleculin Biotech or Forecast & share price targets of Moleculin Biotech
Moleculin Biotech Opened at 2.39 and Closed at: 2.29, which is -6.99% of previous session's close. It moved within a range of 2.25 and 2.51
The session was a Bearish session with an average volume of 111599, which is -3.64% of previous session's volumes.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 2 days back on short term averages
Support for tomorrow is 2.14 and resistance for tomorrow is 2.4
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 2.19, 2.09 resistance for tomorrow's hourly charts is 2.45, 2.61
10 Day SMA for Moleculin Biotech (MBRX) is 2.68 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Moleculin Biotech (MBRX) is 2.75 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Moleculin Biotech (MBRX) is 2.57 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 2.5 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Moleculin Biotech is 2.58 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Moleculin Biotech is at 2.75 and 200 DMA is at 2.58, while 50 DMA and 100 DMA are at 2.57 and 2.5 respectively
Moleculin Biotech (MBRX) moving average of 20 SMA is at 2.75 and 20 EMA is at 2.62
| Date | Closing Price | 20 SMA | 20 EMA |
| 10 Fri Jul | 2.29 | 2.75 | 2.62 |
| 09 Thu Jul | 2.45 | 2.76 | 2.66 |
| 08 Wed Jul | 2.35 | 2.76 | 2.68 |
| 07 Tue Jul | 2.28 | 2.77 | 2.71 |
| 06 Mon Jul | 2.40 | 2.77 | 2.76 |
| 02 Thu Jul | 2.64 | 2.78 | 2.8 |
Moleculin Biotech (MBRX) moving average of 50 SMA is at 2.57 and 50 EMA is at 2.63
| Date | Closing Price | 50 SMA | 50 EMA |
| 10 Fri Jul | 2.29 | 2.57 | 2.63 |
| 09 Thu Jul | 2.45 | 2.57 | 2.64 |
| 08 Wed Jul | 2.35 | 2.57 | 2.65 |
| 07 Tue Jul | 2.28 | 2.58 | 2.66 |
| 06 Mon Jul | 2.40 | 2.58 | 2.68 |
| 02 Thu Jul | 2.64 | 2.58 | 2.69 |
Moleculin Biotech (MBRX) moving average of 100 SMA is at 2.5 and 100 EMA is at 2.65
| Date | Closing Price | 100 SMA | 100 EMA |
| 10 Fri Jul | 2.29 | 2.5 | 2.65 |
| 09 Thu Jul | 2.45 | 2.53 | 2.66 |
| 08 Wed Jul | 2.35 | 2.54 | 2.66 |
| 07 Tue Jul | 2.28 | 2.56 | 2.67 |
| 06 Mon Jul | 2.40 | 2.58 | 2.68 |
| 02 Thu Jul | 2.64 | 2.6 | 2.69 |
Moleculin Biotech (MBRX) moving average of 200 SMA is at 2.58 and 200 EMA is at 2.46
| Date | Closing Price | 200 SMA | 200 EMA |
| 10 Fri Jul | 2.29 | 2.58 | 2.46 |
| 09 Thu Jul | 2.45 | 2.57 | 2.46 |
| 08 Wed Jul | 2.35 | 2.56 | 2.46 |
| 07 Tue Jul | 2.28 | 2.55 | 2.46 |
| 06 Mon Jul | 2.40 | 2.54 | 2.46 |
| 02 Thu Jul | 2.64 | 2.53 | 2.46 |
Tandem Diabetes has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Tandem Diabetes, about 12.72% more returns!
Moleculin Biotech has performed better than Synergetics Usa in short term. Holding Moleculin Biotech could be a better choice for now!
Supernus Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 21.56% more returns!
Staar Surgical has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Staar Surgical, about 11.21% more returns!
Sensus Healthcare has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Sensus Healthcare, about 27% more returns!
Puma Biotechnology has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Puma Biotechnology, about 25.84% more returns!
Mustang Bio has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Mustang Bio, about 0.19% more returns!
Liquidia Technologies has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Liquidia Technologies, about 24.03% more returns!
Lipocine Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Lipocine Inc, about 25.19% more returns!
Akari Therapeutics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Akari Therapeutics, about 8.58% more returns!
Atara Biotherapeutics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Atara Biotherapeutics, about 7.94% more returns!
Biolife Solutions has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Biolife Solutions, about 21.13% more returns!
Catalyst Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Catalyst Pharmaceuticals, about 15.54% more returns!
Curis Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Curis Inc, about 1087.28% more returns!
Citius Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Citius Pharmaceuticals, about 18.7% more returns!
Delcath Systems has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Delcath Systems, about 25.81% more returns!
Fulgent Genetics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Fulgent Genetics, about 24.72% more returns!
Inmune Bio has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Inmune Bio, about 66.75% more returns!
Moleculin Biotech has performed better than Jaguar Health in short term. Holding Moleculin Biotech could be a better choice for now!
Moleculin Biotech Technical analysis of indicators
Price action analysis of Moleculin Biotech (MBRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Moleculin Biotech stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Moleculin Biotech in short term and the sell signal is strong.
Moleculin Biotech Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Moleculin Biotech in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Moleculin Biotech is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.98 and Moleculin Biotech MBRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Moleculin Biotech MBRX stock. Volume based technical analysis of Moleculin Biotech MBRX stock is negative.
Moleculin Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock MBRX Moleculin Biotech These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MBRX Experts View which covers a lot of information including buying and selling signals
MBRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Moleculin Biotech or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


